November 13, 2013
  • Beta Blockers May Increase Risk of Cardiac Events in Surgical Patients

    A new study raises questions about the American College of Cardiology/American Heart Association (ACC/AHA) 2011 guideline recommendations of beta-blockers for perioperative cardiac risk stratification and management. In fact, a poster at a recent conference suggests that the antihypertensives actually may increase the risk of adverse cardiac events in patients undergoing a noncardiac surgical procedure.

  • New Drug Shows Promise in Treating
    Parkinson’s Psychosis

    A new drug could be beneficial for millions of patients worldwide who suffer from Parkinson’s disease. An industry-funded Phase 3 randomized trial indicates that pimavanserin can improve psychosis, a condition that affects about half of Parkinson’s patients. Find out more.

  • Asthma, COPD Patients Must Switch From Final Two CFC Inhalers This Year

    All inhaler medical products containing chlorofluorocarbons will be off the market in the United States by the end of the year. Here is how pharmacists can advise asthma and COPD patients about alternatives as well about the continued usability of those products filled before December 31.

  • Omega-3 Fatty Acid Supplements: Too Much of
    a Good Thing?

    Touted as beneficial for cardiac health, omega-3 fatty acids are popular supplements in forms such as fish oil. A new study, however, warns that too much of the long chain polyunstaurated fatty acids can adversely affect the immune system. The problem, according to the authors, is that no one knows how much is too much, even with many products now fortified with omega-3s.

U.S. Pharmacist Social Connect